Injection frequency plays a large role in visual acuity outcomes. However, there does seem to be a ceiling effect at 10 injections, says David F. Williams, MD. Why is this?
In the largest phase II trial evaluating dry AMD to date, the effect of APL-2 was greatest in the second 6 months of treatment. Nathan Steinle, MD, explains why.
This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.
This email was sent by: %%Member_Busname%% %%Member_Addr%% %%Member_City%%, %%Member_State%%, %%Member_PostalCode%%, %%Member_Country%%
